New York, NY, November 11, 2009-Ebitda News reports that negative EBITDA for Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) for its quarter ended September 30, 2009 was $(26,290,000), a 31% improvement ove ... read full story
Stocks closed the at session highs after trading in a tight range for most of the day. Investors remained on the sidelines for most of the session due to a lack of market direction and concerns regarding inflation in China, but the S&P closed above t ... read full story
0.00 
